Mumbai: Women in India are at higher risk of developing cardiovascular disease (CVD) as early symptoms such as angina are difficult to detect due to atypical symptoms, which can pose a challenge in diagnosis, an association of physicians said on Wednesday.
Dr Milind Y Nadkar, president of the Association of Physicians of India (API), said here that Indians experience cardiovascular diseases a decade earlier than western countries, leading to younger onset of disease and faster progression of disease. It becomes necessary to treat it timely.
"Women are more likely than men to exhibit atypical symptoms such as jaw or neck pain, fatigue, and non-chest discomfort, which can pose a challenge in diagnosis. This can result in doctors treating symptomatic angina without addressing the underlying angina cause. What lies ahead is further exacerbated when patients deny the existence of their symptoms," Nadkar said at a press conference.
CVD is a group of disorders of the heart and blood vessels and is the leading cause of death globally.According to the data, India ranks second worldwide in terms of cardiovascular disease-related mortality and the contribution of CVD to the annual mortality rate of men and women in the country is 20.3 per cent and 16.9 per cent respectively.
"Obesity is also a strong risk factor for angina, especially in women. People with diabetes also report more extensive coronary disease if left untreated," Nadkar said.
He said the incidence of angina (a type of chest pain caused by reduced blood flow to the heart) in women is lower than that of men, but it is increasing due to lifestyle and demographic patterns.
Coronary artery disease (CAD) mortality rates are 20-50 percent higher among Indians than any other population.Moreover, according to API, the apex professional body of consultant physicians in the country, CAD-related mortality and disability rates have doubled in the last 30 years in India.
"People often exhibit atypical angina symptoms, which may lead to missed diagnosis, such as shortness of breath, excessive sweating, heartburn, nausea, or stable angina, a type of chest pain that is triggered by emotional or physical stress or exercise. "Women are more likely than men to exhibit atypical symptoms such as jaw or neck pain, fatigue and non-chest discomfort, which can pose a challenge in diagnosis," Nadkar stressed.
This may result in doctors offering symptomatic relief solutions without addressing the underlying angina causes, which is exacerbated when patients deny the existence of their symptoms, the API president said.
“Indians experience CVD a decade earlier than Westerners, making it important to treat the disease early in life with early onset and rapidly progressive disease.“India is recording the highest rate of coronary artery disease in the world, so it is important to bring more awareness about symptoms like angina,” he said.
Dr Ashwini Pawar, Medical Director, Abbott India, who also addressed the press conference, said, "Angina remains an under-diagnosed condition in India. As a result, many people do not receive optimal treatment. Given the increasing burden It is important to address this challenge.” The cost of CVD and its associated costs to the country is estimated to be approximately US$2.17 trillion between 2012 and 2030.
Dr Milind Y Nadkar, president of the Association of Physicians of India (API), said here that Indians experience cardiovascular diseases a decade earlier than western countries, leading to younger onset of disease and faster progression of disease. It becomes necessary to treat it timely.
"Women are more likely than men to exhibit atypical symptoms such as jaw or neck pain, fatigue, and non-chest discomfort, which can pose a challenge in diagnosis. This can result in doctors treating symptomatic angina without addressing the underlying angina cause. What lies ahead is further exacerbated when patients deny the existence of their symptoms," Nadkar said at a press conference.
CVD is a group of disorders of the heart and blood vessels and is the leading cause of death globally.According to the data, India ranks second worldwide in terms of cardiovascular disease-related mortality and the contribution of CVD to the annual mortality rate of men and women in the country is 20.3 per cent and 16.9 per cent respectively.
"Obesity is also a strong risk factor for angina, especially in women. People with diabetes also report more extensive coronary disease if left untreated," Nadkar said.
He said the incidence of angina (a type of chest pain caused by reduced blood flow to the heart) in women is lower than that of men, but it is increasing due to lifestyle and demographic patterns.
Coronary artery disease (CAD) mortality rates are 20-50 percent higher among Indians than any other population.Moreover, according to API, the apex professional body of consultant physicians in the country, CAD-related mortality and disability rates have doubled in the last 30 years in India.
"People often exhibit atypical angina symptoms, which may lead to missed diagnosis, such as shortness of breath, excessive sweating, heartburn, nausea, or stable angina, a type of chest pain that is triggered by emotional or physical stress or exercise. "Women are more likely than men to exhibit atypical symptoms such as jaw or neck pain, fatigue and non-chest discomfort, which can pose a challenge in diagnosis," Nadkar stressed.
This may result in doctors offering symptomatic relief solutions without addressing the underlying angina causes, which is exacerbated when patients deny the existence of their symptoms, the API president said.
“Indians experience CVD a decade earlier than Westerners, making it important to treat the disease early in life with early onset and rapidly progressive disease.“India is recording the highest rate of coronary artery disease in the world, so it is important to bring more awareness about symptoms like angina,” he said.
Dr Ashwini Pawar, Medical Director, Abbott India, who also addressed the press conference, said, "Angina remains an under-diagnosed condition in India. As a result, many people do not receive optimal treatment. Given the increasing burden It is important to address this challenge.” The cost of CVD and its associated costs to the country is estimated to be approximately US$2.17 trillion between 2012 and 2030.
